VIDA DTC: The associations and impact of brain mineral deposition as a marker of vascular dysfunction and inflammation in neurovascular diseases

VIDA DTC: The associations and impact of brain mineral deposition as a marker of vascular dysfunction and inflammation in neurovascular diseases

Project Code: VIDA_2025_Wardlaw

Iron is involved in oxygen transport, DNA synthesis, cell division, metabolism, and neurotransmission.  However, an excess of iron in brain tissue can lead to oxidative stress damage to biomolecules, and cellular dysfunction. With age, iron and other minerals like calcium, accumulate ‘physiologically’ in deep brain structures, but with a wide variation in the amount: we previously found in older people that excess mineral deposition, which is visible and quantifiable by magnetic resonance imaging (MRI), is associated with cerebral small vessel disease (SVD) on MRI, worse cognitive decline, and increased risks of other neurodegenerative diseases, but the mechanisms are unknown. On pathology, the iron has been associated with blood-brain barrier (BBB) leakage and inflammation, both of which are features of SVD, the commonest cause of vascular dementia. For example, in neuro-immune disorders, dystrophic microglia may be accompanied by iron-laden, perivascular macrophages, suggesting a role of inflammation in iron accumulation. Insoluble mineral deposition has been also observed in perivascular astrocytes, as well as increased perivascular fibrinogen, both implicating BBB disturbance. However, these studies relied on post-mortem tissue, were typically small and reflect end stage disease.

In this project, we will use in vivo MRI from several large longitudinal cohort studies (n~1400) in Edinburgh and London with MRI data on iron, SVD features, and most also with BBB function, to assess relationships of brain iron deposition to SVD features, cognitive and clinical measures, MRI measures of BBB leakage, blood markers of inflammation, and disease progression, with tissue samples available for some subjects. Analysis of MRI-detected iron, BBB leakage, and SVD severity, with blood and cellular biomarkers of vascular and neurodegenerative diseases, longitudinal clinical, cognitive, and demographic data, in four large cohort studies, will help determine the vascular and inflammatory associations and impact of brain iron deposition in neurovascular disease. Secondarily it will identify patterns of iron deposition that may indicate increased risk of vascular dementia. Iron deposition is easily seen on commonly-used clinical MRI sequences meaning that the findings will translate readily to clinical practice and research. The student will learn about imaging in vascular and neurodegenerative diseases including AI techniques, neuroanatomy, a range of MRI image analysis methods, how to manage large data samples, clinical observational and biomarker methods, state of the art statistical analysis, tissue histology, and benefit from training provided by the DPUK and DRI, including Vascular Theme ECR Network, and the two host institutions.

  1. Fandler-Höfler S, Valdés Hernandez M, Chappell F, Makin S, Wardlaw J, Fazekas F, Enzinger C, Werring DJ, Gattringer T et al. Microbleeds International Collaborative Network. Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds. JAMA Netw Open. 2024 Oct 1;7(10):e2439571. doi: 10.1001/jamanetworkopen.2024.39571.
  2. Clancy U, Arteaga-Reyes C, Jaime Garcia D, Hewins W, Locherty R, Valdés Hernández MDC, Wiseman SJ, Stringer MS, Thrippleton M, Chappell FM, Jochems ACC, Liu X, Cheng Y, Zhang J, Rudilosso S, Kampaite A, Hamilton OKL, Brown R, Bastin ME, Muñoz Maniega S, Hamilton I, Job D, Doubal FN, Wardlaw JM. Incident Infarcts in Patients With Stroke and Cerebral Small Vessel Disease: Frequency and Relation to Clinical Outcomes. Neurology. 2024 Sep 10;103(5):e209750. doi: 10.1212/WNL.0000000000209750.
  3. Jin B, Valdés Hernández MDC, Fontanella A, Li W, Platt E, Armitage P, Storkey A, Wardlaw JM, Mair G. Pre-processing and Quality Control of Large Clinical CT Head Datasets for Intracranial Arterial Calcification Segmentation. Lecture Notes in Computer Sciences Vol. 15265 – Data Engineering in Medical Imaging 2024, pp 73-83. Springer https://link.springer.com/chapter/10.1007/978-3-031-73748-0_8
  4. Smith HM, Moodie JE, Monterrubio-Gómez K, Gadd DA, Hillary RF, Chybowska AD, McCartney DL, Campbell A, Redmond P, Page D, Taylor A, Corley J, Harris SE, Valdés Hernández M, Muñoz Maniega S, Bastin ME, Wardlaw JM, Deary IJ, Boardman JP, Mullin DS, Russ TC, Cox SR, Marioni RE. Epigenetic scores of blood-based proteins as biomarkers of general cognitive function and brain health. Clin Epigenetics. 2024 Mar 25;16(1):46. doi: 10.1186/s13148-024-01661-7
  5. Liew SL et al. Association of Brain Age, Lesion Volume, and Functional Outcome in Patients With Stroke. Neurology. 2023. DOI: https://doi.org/10.1212/WNL.0000000000207219

Row Fogo Centre for Research into Ageing and The Brain: https://clinical-brain-sciences.ed.ac.uk/row-fogo-centre-for-research-into-ageing-and-the-brain/about-the-row-fogo-centre

Joanna M. Wardlaw: https://www.ed.ac.uk/profile/professor-joanna-wardlaw, https://ukdri.ac.uk/team/joanna-wardlaw

Maria del C. Valdés Hernández: https:/www.research.ed.ac.uk/en/persons/maria-valdes-hernandez

Blanca Díaz Castro: https://ukdri.ac.uk/team/blanca-diaz-castro

Fatemeh Gerenmayeh: https://profiles.imperial.ac.uk/fatemeh.geranmayeh00

https://www.dementiaresearcher.nihr.ac.uk/vascular-and-immune-contributors-to-dementia/

https://www.alzheimers.org.uk/research/our-research/alzheimers-society-doctoral-training-centres/vascular-and-immune-contributors-dementia

Primary Host Research Centre 

Funding Status of this Project 

Deadline for Application 

Friday, 20 December, 2024

Research Area(s) 

Computational Neuroscience
Dementia (including Alzheimer's disease)
Small vessel disease

Our Approaches 

Neuroimaging
Neurovascular
 

Additional Project Info

Additional supervisor: Blanca Díaz Castro, https://ukdri.ac.uk/team/blanca-diaz-castro. VIDA (Vascular and Immune contributors to DementiA) is a new multi-institutional partnership between Alzheimer’s Society and four world-leading research sites: the University of Manchester, University of Edinburgh, Imperial, and City St George’s University of London. With projects focussing on the importance of vascular and immune mechanisms in dementia, VIDA PhD students will become the next generation of much-needed dementia researchers, contributing to breakthroughs in dementia diagnosis and treatment. VIDA students will embark upon a 4 year fully-funded PhD project at one of the four institutions above, with access to the state-of-the-art research facilities and interdisciplinary training available at all sites. Students at each site will come together as a cohort at several points during the programme, most importantly for an induction week at the beginning of the programme, followed by annual conferences and residential workshop retreats which will link in with other Alzheimer’s Society Doctoral Training Centres across the UK. Students will also participate in engagement schemes with the Alzheimer’s Society and beyond, sharing the impact of their research in the community. The programme also benefits from built in opportunities for placements with leading industrial partners, and bespoke training plans including schemes to develop teaching, mentoring, and grant writing skills. Successful applicants will receive a generous stipend of £20,500 pa rising by £1,000 each year, and home fees will be covered (international student fees may be covered). Funding is also provided for research expenses, career development and student travel/conference attendance.